Purine derivatives as adenosine A1 receptor ligands

Details for Australian Patent Application No. 2008313789 (hide)

Owner Novartis AG

Inventors Fairhurst, Robin Alec

Agent Davies Collison Cave

Pub. Number AU-A-2008313789

PCT Pub. Number WO2009/050199

Priority 07118719.9 17.10.07 EP

Filing date 15 October 2008

Wipo publication date 23 April 2009

International Classifications

C07D 473/16 (2006.01) Heterocyclic compounds containing purine ring systems

A61K 31/52 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 473/34 (2006.01) Heterocyclic compounds containing purine ring systems

Event Publications

8 April 2010 PCT application entered the National Phase

  PCT publication WO2009/050199 Priority application(s): WO2009/050199

29 April 2010 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Novartis AG, Application No. 2008313789, under INID (54) correct the title to read Purine derivatives as adenosine AL receptor ligands.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008313799-Recovery of residues containing copper and other valuable metals

2008313788-Combination comprising purine derivatives and other compounds and the use thereof for the treatment of inflammatory and obstructive airway diseases